Elevance Health (NYSE:ELV – Get Free Report) had its price target decreased by equities researchers at Morgan Stanley from $359.00 to $352.00 in a report released on Wednesday,MarketScreener reports. The brokerage currently has an “equal weight” rating on the stock. Morgan Stanley’s price target points to a potential upside of 1.78% from the stock’s current […]